CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis

Cancer Research
Michael A JamesMing You

Abstract

The transmembrane protein CLPTM1L is overexpressed in non-small cell lung cancer, where it protects tumor cells from genotoxic apoptosis. Here, we show that RNA interference-mediated blockade of CLPTM1L inhibits K-Ras-induced lung tumorigenesis. CLPTM1L expression was required in vitro for morphologic transformation by H-RasV12 or K-RasV12, anchorage-independent growth, and survival of anoikis of lung tumor cells. Mechanistic investigations indicated that CLPTM1L interacts with phosphoinositide 3-kinase and is essential for Ras-induced AKT phosphorylation. Furthermore that the anti-apoptotic protein Bcl-xL is regulated by CLPTM1L independently of AKT activation. Constitutive activation of AKT or Bcl-xL rescued the transformed phenotype in CLPTM1L-depleted cells. The CLPTM1L gene lies within a cancer susceptibility locus at chromosome 5p15.33 defined by genome-wide association studies. The risk genotype at the CLPTM1L locus was associated with high expression of CLPTM1L in normal lung tissue, suggesting that cis-regulation of CLPTM1L may contribute to lung cancer risk. Taken together, our results establish a protumorigenic role for CLPTM1L that is critical for Ras-driven lung cancers, with potential implications for therapy and ...Continue Reading

References

Mar 25, 2000·Molecular and Cellular Biology·C ChenC Gélinas
Nov 21, 2000·Current Opinion in Oncology·J M GradL H Boise
Feb 13, 2001·Biochemical and Biophysical Research Communications·K YamamotoY Ohtake
Dec 1, 2001·The Journal of Biological Chemistry·Lindsey D MayoDavid B Donner
Sep 10, 2002·Trends in Biochemical Sciences·Lindsey D Mayo, David B Donner
May 12, 2007·Acta Biochimica Et Biophysica Sinica·Xiaoyong LeiDuanfang Liao
Nov 4, 2008·Nature Genetics·Yufei WangRichard S Houlston
Nov 4, 2008·Nature Genetics·James D McKayPaul Brennan
Jan 20, 2009·Nature Genetics·Thorunn RafnarKari Stefansson
Feb 10, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Pengyuan LiuMing You
Mar 11, 2010·Current Pharmaceutical Design·Amancio Carnero
Jun 22, 2010·Nature·Christian BehrendsJ Wade Harper
Jun 24, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karen A PooleyAlison M Dunning
Jul 3, 2010·Human Mutation·Lisa MirabelloSharon A Savage
May 31, 2011·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chi-Hau Chen, Ruey-Jien Chen
Jul 21, 2011·Carcinogenesis·Mala PandeChristopher I Amos
Mar 1, 2012·Genetics and Molecular Research : GMR·X F ChenX B Wang
Apr 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gord FehringerRayjean J Hung
Aug 18, 2012·Human Molecular Genetics·Maria N TimofeevaUNKNOWN Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Sep 4, 2012·Nature Genetics·Elin GrundbergUNKNOWN Multiple Tissue Human Expression Resource (MuTHER) Consortium
Jan 10, 2013·PloS One·Zhenhua NiXiongbiao Wang

❮ Previous
Next ❯

Citations

Apr 12, 2016·Cancer Biomarkers : Section a of Disease Markers·Zhenhua NiXiongbiao Wang
Mar 1, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chengli LiuHongyi Zhang
Feb 19, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yuansheng ZangBing Li
Aug 27, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yiqian LiangMingwei Chen
Jul 11, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Karima Ait-AissaAndreas M Beyer
Mar 24, 2017·International Journal of Cancer. Journal International Du Cancer·Jing DongHongbing Shen
Nov 24, 2018·International Journal of Cancer. Journal International Du Cancer·William R ClarkeMichael A James
Aug 5, 2014·Nature Genetics·Brian M WolpinLaufey T Amundadottir
May 10, 2019·NPJ Precision Oncology·Hongbing ShenCheng Wang
Aug 7, 2017·NPJ Genomic Medicine·Lenha MobuchonMarc-Henri Stern
Jan 10, 2020·Journal of the National Cancer Institute·Jun ZhongLaufey T Amundadottir
Jun 21, 2020·International Journal of Molecular Sciences·Sarah RenaudNadira Delhem
Apr 11, 2020·Nature Reviews. Disease Primers·Martine J JagerBertil E Damato
Jan 13, 2019·Journal of Cancer Research and Clinical Oncology·Keisuke InoueTamotsu Takeuchi
Jun 16, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yohan Bossé, Christopher I Amos
Aug 24, 2021·Journal of the National Cancer Institute·Lenha MobuchonMarc-Henri Stern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis